Meabco Inc
CAGE Code: 8C2F1
NCAGE Code: 8C2F1
Status: Active
Type: Commercial Supplier
Summary
Meabco Inc is an Active Commercial Supplier with the Cage Code 8C2F1.
Address
875 N Michigan Ave Ste 3950
Chicago IL 60611-2693
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Platinu-Mennium Inc Deco-Pac Ltd Harbor Government Solutions, Llc Marcal Paper Mills Inc Barracudas Computer Solutions Llc Samuels Custom Picture Framing Connect 2100 Hay Jacob Co Kirks Inc Hobson Bros Inc Roto Screen Co Quest Mfg Co Moody Video Meredith's Care Partners Llc Woman Made Culver S K Co Scientific Binder Productions Copley Stephen M Md Chicago Industrial Supply Inc Mesirobics
Frequently Asked Questions (FAQ) for CAGE 8C2F1
- What is CAGE Code 8C2F1?
- 8C2F1 is the unique identifier used by NATO Organizations to reference the physical entity known as Meabco Inc located at 875 N Michigan Ave Ste 3950, Chicago IL 60611-2693, United States.
- Who is CAGE Code 8C2F1?
- 8C2F1 refers to Meabco Inc located at 875 N Michigan Ave Ste 3950, Chicago IL 60611-2693, United States.
- Where is CAGE Code 8C2F1 Located?
- CAGE Code 8C2F1 is located in Chicago, IL, USA.
Contracting History for CAGE 8C2F1 Most Recent 25 Records
- 75N93020C00004
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- 26 Aug 2022
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $6,434,350.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00004
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- 28 Feb 2023
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $6,434,350.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00004
- Ipp: Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- 15 Nov 2022
- Ipp: Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $6,434,350.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00004
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- 19 Jul 2022
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $6,395,350.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00004
- Ipp: Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- 2 Feb 2023
- Ipp: Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $6,434,350.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00004
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- 5 Sep 2023
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $6,434,350.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00004
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- 28 Apr 2022
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $6,368,117.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00004
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- 13 Jul 2022
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $6,368,117.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00004
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- 15 Sep 2021
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $4,398,977.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00004
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- 27 Apr 2023
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $6,434,350.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00004
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- 1 Dec 2021
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $4,398,977.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00004
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- 13 Jul 2021
- Ermes Evaluation Of Radiomitigative Efficacy And Safety Of Bp-C2
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $3,993,332.00
- Department Of Health And Human Services (Hhs)